Renta 4 Banco S.A. (0KBY)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 19.45 |
|---|---|
| 52-week range | 13.21 – 20.20 |
| Return, 1 month / 3 months | +0.3% / +1.8% |
| Return, 1 year / 3 years | +47.2% / – |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 19.2% |
| Worst drawdown (1 year) | -11.0% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Renta 4 Banco is a Spanish bank that concentrates on private banking, brokerage and wealth management. It serves individual investors and institutions with services such as securities dealing, investment fund management, portfolio advice and custody of financial assets. The bank also provides corporate finance and treasury services to its clients. It is based in Madrid and operates through a branch network across Spain, with additional offices in other European and Latin American markets.
Renta 4 Banco S.A. trades under the code 0KBY on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Renta 4 Banco S.A. (0KBY) trades on the London Exchange in UK. It last closed at EUR 19.45 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,187 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 47.2% and over the last three months it rose 1.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 65 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.0% | ||
| From 52-week high | -1.8% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.8% | ||
| 6-month return | 1.8% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 91 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.0% | ||
| Liquidity | 3 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 28.3% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Income: Dividend is high and has been paid regularly.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | +0.3% |
| 3 months | +1.8% |
| 6 months | +1.8% |
| 1 year | +47.2% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 19.27 / 19.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.18 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Apr 2026 | EUR 0.2025 |
| 3 Nov 2025 | EUR 0.3645 |
| 4 Apr 2025 | EUR 0.1296 |
| 4 Nov 2024 | EUR 0.3038 |
| 10 Apr 2024 | EUR 0.0972 |
| 3 Nov 2023 | EUR 0.2430 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.